Real-time enrollment status for this primary membranous nephropathy clinical trial
Current Status
Unknown
Checked: June 1, 2026 at 9:50 PM UTC
| NCT Number | NCT05696613 |
| Recruiting Status | Unknown |
| Condition | Primary Membranous Nephropathy |
| Phase | Clinical Trial |
| Target Enrollment | 148 participants |
| Active Locations | 19 sites in the US |
| Sponsor | Cerium Pharmaceuticals, Inc. |
| Last Updated on CT.gov | April 25, 2024 (Apr 25, 2024) |
As of June 1, 2026: Clinical trial NCT05696613 is currently unknown participants. This clinical trial study for primary membranous nephropathy is not currently accepting new participants at 19 locations across the United States. The study is sponsored by Cerium Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05696613 is currently unknown. The study may resume recruiting in the future.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05696613 was last updated Apr 25, 2024 (April 25, 2024). HelloStudys verifies this status automatically.